Telerehabilitation through internet improve life of women suffering breast cancer

January 11, 2017
Webpage of the system e-CUÍ. Credit: UGRdivulga

Researchers from the University of Granada (UGR) and from hospitals Virgen de las Nieves and San Cecilio (Granada) have proved that telerehabilitation may help to alleviate the side effects associated with breast cancer and its treatment, including pain, fatigue, strength loss, and deterioration of the quality of life. In their study, they conducted rehabilitation with the help of the internet, using the application Skype as a control platform.

The characteristics of the telerehabilitation system conceived by the scientists, called e-CUIDATE ('cuídate' meaning 'take care'), make this study about telehealth one of the most complete thus far with patients suffering breast cancer, producing excellent results for the offered via the Internet both for the possible side effects and the final outcome of the treatment.

Noelia Galiano Castillo, belonging to the department of Physical Therapy and main author of the work, explains, "The participants have ameliorated their pain, strength, fatigue and quality of life, which reflects that an eight-week exercise program over the Internet can be successfully conducted without the need for a in-person therapeutic strategy."

Moreover, patients who took this telerehabilitation program maintained the benefits of the exercise program six months after its completion.

This online, using a website may help to ameliorate their symptoms and functional levels through the use of information and communication technologies (ICT); in this case, by means of the system e-CUIDATE.

Explore further: Telerehabilitation through Internet ameliorate the life of women suffering breast cancer

More information: Noelia Galiano-Castillo et al, Telehealth system: A randomized controlled trial evaluating the impact of an internet-based exercise intervention on quality of life, pain, muscle strength, and fatigue in breast cancer survivors, Cancer (2016). DOI: 10.1002/cncr.30172

Related Stories

Recommended for you

Savior of T-cells may be enemy of liver immune cells

April 24, 2017

Researchers at Houston Methodist demonstrated that a surface protein called OX40, responsible for keeping one type of immune system cell alive, can trigger the death of liver immune cells, in turn starting a chain reaction ...

How gut bacteria change cancer drug activity

April 21, 2017

The activity of cancer drugs changes depending on the types of microbes living in the gut, according to a UCL-led study into how nematode worms and their microbes process drugs and nutrients.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.